DNA polymerase ζ suppresses the radiosensitivity of glioma cells by regulating the PI3K/AKT/mTOR pathway

References

• Louis DN, Perry A, Wesseling P, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. 2021;23(8):1–8. doi:10.1093/neuonc/noab106
   PubMed Web of Science ®Google Scholar
• Lin J, Bytnar JA, Theeler BJ, et al. Survival among patients with glioma in the US military health system: a comparison with patients in the surveillance, epidemiology, and end results program. Cancer. 2020;126(13):3053–3060. doi:10.1002/cncr.32884
   PubMed Web of Science ®Google Scholar
• Wang TJC, Mehta MP. Low-grade glioma radiotherapy treatment and trials. Neurosurg Clin N Am. 2019;30(1):111–118. doi:10.1016/j.nec.2018.08.008
   PubMed Web of Science ®Google Scholar
• Mudassar F, Shen H, O'Neill G, et al. Targeting tumor hypoxia and mitochondrial metabolism with anti-parasitic drugs to improve radiation response in high-grade gliomas. J Exp Clin Cancer Res. 2020;39(1):208. doi:10.1186/s13046-020-01724-6
   PubMed Web of Science ®Google Scholar
• Xu S, Tang L, Li X, et al. Immunotherapy for glioma: current management and future application. Cancer Lett. 2020;476:1–12. doi:10.1016/j.canlet.2020.02.002
   PubMed Web of Science ®Google Scholar
• Wang Y, Liu ZG, Yuan H, et al. The reciprocity between radiotherapy and cancer immunotherapy. Clin Cancer Res. 2019;25(6):1709–1717. doi:10.1158/1078-0432.CCR-18-2581
   PubMed Web of Science ®Google Scholar
• Daubon T, Hemadou A, Romero Garmendia I, et al. Glioblastoma immune landscape and the potential of new immunotherapies. Front Immunol. 2020;11:585616. doi:10.3389/fimmu.2020.585616
   PubMed Web of Science ®Google Scholar
• Martin SK, Wood RD. DNA polymerase ζ in DNA replication and repair. Nucleic Acids Res. 2019;47(16):8348–8361. doi:10.1093/nar/gkz705
   PubMed Web of Science ®Google Scholar
• Ben Yamin B, Ahmed-Seghir S, Tomida J, et al. DNA polymerase zeta contributes to heterochromatin replication to prevent genome instability. EMBO J. 2021;40(21):e104543. doi:10.15252/embj.2020104543
   PubMed Web of Science ®Google Scholar
• Zan H, Komori A, Li Z, et al. The translesion DNA polymerase zeta plays a major role in Ig and bcl-6 somatic hypermutation. Immunity. 2001;14(5):643–653. doi:10.1016/S1074-7613(01)00142-X
   PubMed Web of Science ®Google Scholar
• Lange SS, Tomida J, Boulware KS, et al. The polymerase activity of mammalian DNA pol ζ is specifically required for cell and embryonic viability. PLoS Genet. 2016;12(1):e1005759. doi:10.1371/journal.pgen.1005759
   PubMed Web of Science ®Google Scholar
• Shilkin ES, Boldinova EO, Stolyarenko AD, et al. Translesion DNA synthesis and carcinogenesis. Biochemistry. 2020;85(4):425–435. doi:10.1134/S0006297920040033
   PubMed Web of Science ®Google Scholar
• Roos WP, Tsaalbi-Shtylik A, Tsaryk R, et al. The translesion polymerase Rev3L in the tolerance of alkylating anticancer drugs. Mol Pharmacol. 2009;76(4):927–934. doi:10.1124/mol.109.058131
   PubMed Web of Science ®Google Scholar
• Yang J, Ding W, Wang X, et al. Knockdown of DNA polymerase ζ relieved the chemoresistance of glioma via inhibiting the PI3K/AKT signaling pathway. Bioengineered. 2021;12(1):3924–3933. doi:10.1080/21655979.2021.1944027
   PubMed Web of Science ®Google Scholar
• Chen X, Ji R, Liu J, et al. Roles of DNA polymerase ζ in the radiotherapy sensitivity and oxidative stress of lung cancer cells. Cancer Chemother Pharmacol. 2022;89(3):313–321. doi:10.1007/s00280-021-04360-9
   PubMed Web of Science ®Google Scholar
• Sharma S, Canman CE. REV1 and DNA polymerase zeta in DNA interstrand crosslink repair. Environ Mol Mutagen. 2012;53(9):725–740. doi:10.1002/em.21736
   PubMed Web of Science ®Google Scholar
• Zan H, Shima N, Xu Z, et al. The translesion DNA polymerase theta plays a dominant role in immunoglobulin gene somatic hypermutation. EMBO J. 2005;24(21):3757–3769. doi:10.1038/sj.emboj.7600833
   PubMed Web of Science ®Google Scholar
• Nicolay NH, Helleday T, Sharma RA. Biological relevance of DNA polymerase β and translesion synthesis polymerases to cancer and its treatment. Curr Mol Pharmacol. 2012;5(1):54–67. doi:10.2174/1874467211205010054
   PubMedGoogle Scholar
• Mohni KN, Thompson PS, Luzwick JW, et al. A synthetic lethal screen identifies DNA repair pathways that sensitize cancer cells to combined ATR inhibition and cisplatin treatments. PLOS One. 2015;10(5):e0125482. doi:10.1371/journal.pone.0125482
   PubMed Web of Science ®Google Scholar
• Wang W, Sheng W, Yu C, et al. REV3L modulates cisplatin sensitivity of non-small cell lung cancer H1299 cells. Oncol Rep. 2015;34(3):1460–1468. doi:10.3892/or.2015.4121
   PubMed Web of Science ®Google Scholar
• Lin X, Trang J, Okuda T, et al. DNA polymerase zeta accounts for the reduced cytotoxicity and enhanced mutagenicity of cisplatin in human colon carcinoma cells that have lost DNA mismatch repair. Clin Cancer Res. 2006;12(2):563–568. doi:10.1158/1078-0432.CCR-05-1380
   PubMed Web of Science ®Google Scholar
• Shi TY, Yang L, Yang G, et al. DNA polymerase ζ as a potential biomarker of chemoradiation resistance and poor prognosis for cervical cancer. Med Oncol. 2013;30(2):500. doi:10.1007/s12032-013-0500-4
   PubMed Web of Science ®Google Scholar
• Cao W, Gu Y, Meineck M, et al. The combination of chemotherapy and radiotherapy towards more efficient drug delivery. Chem Asian J. 2014;9(1):48–57. doi:10.1002/asia.201301294
   PubMed Web of Science ®Google Scholar
• Polivka JJr., Janku F. Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway. Pharmacol Ther. 2014;142(2):164–175. doi:10.1016/j.pharmthera.2013.12.004
   PubMed Web of Science ®Google Scholar
• Shahcheraghi SH, Tchokonte-Nana V, Lotfi M, et al. Wnt/beta-catenin and PI3K/Akt/mTOR signaling pathways in glioblastoma: two main targets for drug design: a review. Curr Pharm Des. 2020;26(15):1729–1741. doi:10.2174/1381612826666200131100630
   PubMed Web of Science ®Google Scholar
• Alzahrani AS. PI3K/akt/mTOR inhibitors in cancer: at the bench and bedside. Semin Cancer Biol. 2019;59:125–132. doi:10.1016/j.semcancer.2019.07.009
   PubMed Web of Science ®Google Scholar
• Akbarzadeh M, Mihanfar A, Akbarzadeh S, et al. Crosstalk between miRNA and PI3K/AKT/mTOR signaling pathway in cancer. Life Sci. 2021;285:119984. doi:10.1016/j.lfs.2021.119984
   PubMed Web of Science ®Google Scholar
• Bamodu OA, Chang HL, Ong JR, et al. Elevated PDK1 expression drives PI3K/AKT/mTOR signaling promotes radiation-resistant and dedifferentiated phenotype of hepatocellular carcinoma. Cells. 2020;9(3):746. doi:10.3390/cells9030746
   PubMed Web of Science ®Google Scholar
• Liu Y, Shen Y, Sun T, et al. Mechanisms regulating radiosensitivity of glioma stem cells. Neoplasma. 2017;64(5):655–665. doi:10.4149/neo_2017_502
   PubMed Web of Science ®Google Scholar